Thyroid Drug Shortage Presents Tough Choices for Cancer Patients
A company spokeswoman attributes the shortage to the company’s inability to meet increasing demand and the transition to a new plant for bottling and labeling operations.
Read MorePosted by Clinical Lab Products | May 27, 2011 | Cancer, Miscellaneous |
A company spokeswoman attributes the shortage to the company’s inability to meet increasing demand and the transition to a new plant for bottling and labeling operations.
Read MorePosted by Clinical Lab Products | May 1, 2011 | Cancer, Miscellaneous |
BioCare Medical LLC offers a new look at prostate cancer diagnosis.
Read MorePosted by Clinical Lab Products | Apr 6, 2011 | Cancer |
Amgen Cancer Drug Fails in Phase 3 Study Thousand Oaks, Calif — Amgen, Cambridge, Mass-based Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Co, Osaka, Japan, announced the top-line results from the pivotal
Read MorePosted by Clinical Lab Products | Mar 13, 2011 | Miscellaneous |
Sunesis Pharmaceuticals’ vosaroxin would be used in combination with cytarabine to treat acute myeloid leukemia.
Read MorePosted by Clinical Lab Products | Mar 5, 2011 | Cancer, Dementias & Alzheimer’s, Pancreatic |
Positive Early Results for Parkinson’s Treatment Michael J. Fox Harbor BioSciences, San Diego, which is investigating the use the company’s proprietary compound Triolex as a treatment for Parkinson’s disease (PD) with fund
Read More